Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: SCANTOX NEURO GMBH
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-30 to 2025-04-30
Current total value of award: $249334
Description: EOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI  NOTICE OF TERMINATION FOR CONVENIENCE  PHARMACODYNAMIC AND TOLERABILITY STUDIES OF CANDIDATE AD DRUGS IN A TRANSGENIC AD MOUSE MO